Literature DB >> 24635389

Pharmaceutical properties of calycosin, the major bioactive isoflavonoid in the dry root extract of Radix astragali.

JunQing Gao1, Zong Jun Liu, Tao Chen, DeQiang Zhao.   

Abstract

CONTEXT: Radix astragali (Fabaceae astragalus propinquus Schischkin) is a Chinese medicinal herb traditionally used for the treatment of several diseases. Calycosin is the major bioactive chemical in the dry root extract of this medical plant.
OBJECTIVE: This work presents a brief overview of recent reports on the potential effects of calycosin on several diseases and the possible mechanisms of action of this chemical.
MATERIALS AND METHODS: This review gathers information from the scientific literature (before 1 June 2013) that was compiled from various databases, such as Science Direct, PubMed, Google Scholar, and Scopus.
RESULTS: The potential pharmaceutical properties of calycosin in the treatment of tumors, inflammation, stroke, and cardiovascular diseases have gained increasing attention in the recent years. The literature survey showed that calycosin exhibits promising effects for the treatment of several diseases and that these effects may be due to its isoflavonoid and phytoestrogenic properties. The effects of calycosin most likely result from its interaction with the ER receptors on the cell membrane and the modulation of the MAPK signaling pathway.
CONCLUSION: Calycosin exhibits great potential as a therapeutic drug and may be a successful example of the standardization and modernization of traditional Chinese herbal medicine.

Entities:  

Keywords:  Anti-inflammatory; antioxidative; antitumor; cardiovascular; herbal medicine; neuro-protective

Mesh:

Substances:

Year:  2014        PMID: 24635389     DOI: 10.3109/13880209.2013.879188

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  26 in total

Review 1.  Electrochemical sensors and biosensors based on the use of polyaniline and its nanocomposites: a review on recent advances.

Authors:  Nahid Shoaie; Maryam Daneshpour; Mostafa Azimzadeh; Sara Mahshid; Seyyed Mehdi Khoshfetrat; Fatemeh Jahanpeyma; Alieh Gholaminejad; Kobra Omidfar; Mehdi Foruzandeh
Journal:  Mikrochim Acta       Date:  2019-06-24       Impact factor: 5.833

2.  Calycosin induces apoptosis in human ovarian cancer SKOV3 cells by activating caspases and Bcl-2 family proteins.

Authors:  Yan Zhou; Qing-Hua Liu; Chun-Lei Liu; Li Lin
Journal:  Tumour Biol       Date:  2015-02-12

3.  MUC1 is responsible for the pro-metastatic potential of calycosin in pancreatic ductal adenocarcinoma.

Authors:  Wenqing Chen; Zhu Zhang; Ken Kin-Lam Yung; Joshua Ka-Shun Ko
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

Review 4.  Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line.

Authors:  Citra Dewi; Adryan Fristiohady; Riezki Amalia; Nur Kusaira Khairul Ikram; Sugeng Ibrahim; Muchtaridi Muchtaridi
Journal:  Molecules       Date:  2022-06-07       Impact factor: 4.927

5.  Calycosin down-regulates c-Met to suppress development of glioblastomas.

Authors:  Xiaohu Nie; Yue Zhou; Xiaobing Li; Jie Xu; Xuyan Pan; Rui Yin; Bin Lu
Journal:  J Biosci       Date:  2019-09       Impact factor: 1.826

6.  A Network Pharmacology Approach to Predict the Proangiogenesis Mechanism of Huangqi-Honghua Herb Pair after Cerebral Ischemia.

Authors:  Jinyi Cao; Lu Lei; Kai Wang; Jing Sun; Yi Qiao; Jialin Duan; Chao Zhao; Jia Cui; Zhijun Feng; Jing-Wen Wang; Aidong Wen; Zhifu Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-14       Impact factor: 2.629

Review 7.  Pharmaceutical Values of Calycosin: One Type of Flavonoid Isolated from Astragalus.

Authors:  Guowei Gong; Yuzhong Zheng; Yang Yang; Yixuan Sui; Zhen Wen
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-06       Impact factor: 2.629

8.  Intraspecific and heteroplasmic variations, gene losses and inversions in the chloroplast genome of Astragalus membranaceus.

Authors:  Wanjun Lei; Dapeng Ni; Yujun Wang; Junjie Shao; Xincun Wang; Dan Yang; Jinsheng Wang; Haimei Chen; Chang Liu
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

9.  Calycosin-loaded nanoliposomes as potential nanoplatforms for treatment of diabetic nephropathy through regulation of mitochondrial respiratory function.

Authors:  Chunrong Huang; Lian-Fang Xue; Bo Hu; Huan-Huan Liu; Si-Bo Huang; Suliman Khan; Yu Meng
Journal:  J Nanobiotechnology       Date:  2021-06-13       Impact factor: 10.435

10.  Tongguan capsule ameliorates coronary artery stenosis in a 40-year-old woman.

Authors:  Huan Ma; Lei Wang; Daozheng Huang; Guoqing Liu; Minzhou Zhang
Journal:  Drug Des Devel Ther       Date:  2015-08-10       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.